ASTRAZENECA INVESTS OVER $60 MILLION IN EXPANDED PRODUCTION FACILITIES FOR ‘SEROQUEL’
16-Jan-2001 -
AstraZeneca is investing $60 million (over £37
million) at its manufacturing site in Macclesfield, Cheshire, UK, to meet the rapid growth
in global demand for 'Seroquel', the atypical antipsychotic.
This investment is in two stages: $42 million will provide a new,
general purpose tablets ...
antipsychotics
AstraZeneca
central nervous system
+2